The answer is in data analytics firm YouGov’s recent ranking of the most-loved chains. Food & Wine reports that YouGov’s researchers interviewed 1220 people in the U.S. from October to ...

Reimagining chain mail 3D architected materials that adapt and protect Date: January 21, 2025 Source: California Institute of Technology Summary: Experiments have yielded a fascinating new type of ...

In a significant shift reflecting the complexities of the modern geopolitical landscape, nearly three-quarters of businesses worldwide are revamping their supply chains to engage with a larger ...

Kevin O'Marah, the chief research officer and co-founder of Zero100, a community research platform working towards zero carbon, sheds more light on how supply chains are likely to be impacted by ...

At WEF, China’s dominance came under the microscope, with supply chain issues at the front and centre of concerns. Take, for example, electric vehicles (EVs). Overall EV sales globally have ...

Eli Lilly and Company LLY announced that the FDA has granted approval to its drug, Omvoh (mirikizumab), for its second inflammatory bowel disease (IBD) condition, Crohn's disease (“CD”), in ...

Merck MRK acquired small biotech Prometheus Biosciences in 2023, which added tulisokibart to its pipeline. Merck is developing tulisokibart, a novel TL1A inhibitor, for the treatment of UC ...

Merck faces headwinds like declining sales of the HPV vaccine, Gardasil, and diabetes drug, Januvia. Merck faces broader industry pressure as vaccine skeptic Robert F. Kennedy Jr. possibly next HHS ...

Merck has other promising candidates in its late-stage pipeline, such as MK-0616, an oral PCSK9 inhibitor for hypercholesterolemia, tulisokibart, a TL1A inhibitor for ulcerative colitis and ...